Bloom Science Scores $12M

San Diego=based Bloom Science, a biotech startup developing microbiome-based treatments for neurological and inflammatory disease, says it has raised $12M in its Series A funding. The funding was led by Leaps by Bayer, the impact investment arm of Bayer AG, and the ALS Investment Fund, and also included Apollo Health Ventures, plus existing investor, Joyance Partners. The company said it is initially focusing on treating drug resistant epilepsy and Amyotrophic Lateral Sclerosis (ALS). Christopher Reyes, PhD is CEO and Founder of Bloom Science.